Arcus Biosciences Inc Shares Close the Day 12.2% Lower - Daily Wrap

The company saw its shares close the day 12.2% lower than yesterday, with trading volume lower than its 30 day average.

Jun 13, 2022 by Kwhen Finance Editors

Arcus Biosciences Inc Shares Close the Day 12.2% Lower - Daily Wrap
Arcus Biosciences Inc (RCUS) shares closed today 12.2% lower than it did at the end of yesterday. The stock is currently down 44.4% year-to-date, down 9.5% over the past 12 months, and up 32.5% over the past five years. Today, the Dow Jones Industrial Average fell 2.8%, and the S&P 500 fell 3.8%.

Trading Activity

  • Shares traded as high as $24.08 and as low as $21.55 this week.
  • Shares closed 59.7% below its 52-week high and 18.1% above its 52-week low.
  • Trading volume this week was 26.2% higher than the 10-day average and 0.0% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was between 30 and 70.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Arcus Biosciences Inc-12.2-44.4-9.5-55.929.2
Dow Jones Industrial Average-2.8-12.8-7.3-13.23.9
S&P 500 Index-3.8-17.7-6.9-17.53.8
Health Care-1.7-12.4-1.6-12.61.6

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 48.9%
  • The company's stock price performance over the past 12 months beats the peer average by -72.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Arcus Biosciences IncRCUS0-44.4-9.5-55.929.2
Peer AvgN/A0-29.8-34.2
Ovid Therapeutics IncOVID0-41.1-57.9
Oyster Point Pharma IncOYST0-78.0-78.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: